Location History:
- Tigard, OR (US) (2015)
- Fremont, CA (US) (2022 - 2023)
Company Filing History:
Years Active: 2015-2023
Title: Jiang Li: Innovator in Array-Based Genetic Analysis
Introduction
Jiang Li is a prominent inventor based in Fremont, CA, known for his contributions to the field of genetic analysis. He holds a total of 3 patents that focus on innovative methods for analyzing mixed nucleic acid populations. His work has significant implications for prenatal testing and cancer diagnostics.
Latest Patents
One of Jiang Li's latest patents is titled "Array-based methods for analysing mixed samples using differently labelled allele-specific probes." This patent provides methods and systems useful in array-based analysis of mixed nucleic acid populations. It includes multiplex genotyping of mixed nucleic acid samples and detecting differences in copy number of target polynucleotides and chromosomes. The methods are particularly useful for diagnosing genetic abnormalities in non-invasive samples, such as blood or saliva. Another notable patent is "Array-based methods for analysing mixed samples using different allele-specific labels, in particular for detection of fetal aneuploidies." This patent also focuses on genotyping and copy number analysis of mixed nucleic acid populations.
Career Highlights
Throughout his career, Jiang Li has worked with notable companies, including Affymetrix, Inc. His innovative approaches have contributed to advancements in genetic testing technologies. His patents reflect a deep understanding of molecular biology and its applications in healthcare.
Collaborations
Jiang Li has collaborated with several professionals in his field, including Jeanette Pruzan Schmidt and Orna Mizrahi Man. These collaborations have likely enhanced the development and application of his patented technologies.
Conclusion
Jiang Li's work in array-based genetic analysis showcases his innovative spirit and dedication to improving diagnostic methods. His contributions are paving the way for advancements in prenatal testing and cancer diagnostics, making a significant impact in the field of genetics.